Raphael Pharmaceutical Inc. (RAPH): Shareholders' Equity
-$1.43M
As of 2025-12-31
-$1.89M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.43M | n/m | 2026-03-31, Balance as of period end |
| 2024-12-31 | -$742.0K | n/m | 2026-03-31, Balance as of period end |
| 2023-12-31 | $107.0K | +0.9% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $106.0K | -17.2% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $128.0K | n/m | 2023-05-25, Balance as of period end |
| 2020-12-31 | -$43.0K | n/a | 2022-03-30, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Raphael Pharmaceutical Inc. (RAPH) | 2025-12-31 | -$1.43M | n/m |
| China Foods Holdings Ltd. (CFOO) | 2025-12-31 | -$1.28M | n/m |
| Nutra Pharma Corp (NPHC) | 2025-12-31 | -$16.83M | n/m |
| Adia Nutrition, Inc. (ADIA) | 2025-12-31 | -$257.7K | n/m |
| Aibotics, Inc. (AIBT) | 2025-12-31 | -$3.96M | n/m |
| TFA Therapeutics, Inc. (RAJAF) | 2025-12-31 | -$534.6K | n/m |
| Regencell Bioscience Holdings Ltd (RGC) | 2025-06-30 | $4.86M | -40.9% |
| Target Group Inc. (CBDY) | 2025-12-31 | -$8.06M | n/m |
| Functional Brands Inc. (MEHA) | 2025-12-31 | $1.54M | n/m |
Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗